Insmed | INSM - EPS Earnings Per Share

Stock Price
152.51
Daily Change
-4.65 -2.96%
Monthly
-12.95%
Yearly
87.26%
Q1 Forecast
152.04

Insmed reported $-1.75 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 -1.28 -1.32 Feb/19 2026
FY2025Q3 Sep/2025 -1.75 -1.34 -1.27 Oct/30 2025
FY2025Q2 Jun/2025 -1.70 -1.36 -1.94 Aug/07 2025
FY2025Q1 Mar/2025 -1.42 -1.20 -1.06 May/08 2025
FY2024Q4 Dec/2024 -1.32 -1.18 -1.28 Feb/20 2025




Eps Change Date
BioMarin Pharmaceutical USD 0.12 1.32 Sep/2025
Cytokinetics USD -2.55 1.43 Sep/2025
DBV Technologies USD -0.24 1.31 Sep/2025
Dynavax Technologies USD 0.21 0.07 Sep/2025
Gilead Sciences USD 2.47 0.46 Sep/2025
Insmed USD -1.75 0.05 Sep/2025
Novartis USD 2.02 0.04 Sep/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Sarepta Therapeutics USD -0.13 2.15 Sep/2025
Ultragenyx Pharmaceutical USD -1.81 0.64 Sep/2025
Vertex Pharmaceuticals USD 4.8 0.28 Sep/2025